Impact of restricted access to, and low awareness of, mexiletine on people with myotonia: a real-world European survey

Díaz-Manera, J; Urtizberea, JA; Schey, C; Kole, A; von Gallwitz, P; Whiting, A; Foerster, D; Zozulya-Weidenfeller, A

Díaz-Manera, J (通讯作者),Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, England.

NEUROMUSCULAR DISORDERS, 2023; 33 (2): 208

Abstract

Although mexiletine effectively treats myotonia, supply disruptions affected Europe between 2008- 2018. MyoPath was a mixed-methods, cross-sectional, ......

Full Text Link